The risk / benefit balance continues to weigh "
largely
" in favor of the use of AstraZeneca's anti-Covid vaccine, a World Health Organization official said on Tuesday April 6.
Read also: A lead to explain the rare thromboses linked to the AstraZeneca vaccine
Explaining that experts were gathered this week to discuss a possible link between this vaccine and certain rare types of thrombosis, Rogerio Pinto de Sa Gaspar, WHO director in charge of regulation, insisted on the fact that in l current state of knowledge, the risk / benefit balance "
remains very largely positive
".